Jeff Yass’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.1M | Sell |
7,481
-4,075
| -35% | -$531K | ﹤0.01% | 7963 |
|
|
2026
Q1 | $1.49M | Buy |
+11,556
| New | +$1.66M | ﹤0.01% | 6893 |
|
|
2025
Q3 | – | Sell |
-33,494
| Closed | -$4.24M | – | 13071 |
|
|
2025
Q2 | $4.43M | Sell |
33,494
-31
| -0.1% | -$4.2K | ﹤0.01% | 4198 |
|
|
2025
Q1 | $4.66M | Buy |
33,525
+23,922
| +249% | +$3.71M | ﹤0.01% | 3782 |
|
|
2024
Q4 | $1.49M | Buy |
9,603
+8,463
| +742% | +$1.43M | ﹤0.01% | 5971 |
|
|
2024
Q3 | $208K | Sell |
1,140
-2,823
| -71% | -$418K | ﹤0.01% | 10392 |
|
|
2024
Q2 | $471K | Sell |
3,963
-6,201
| -61% | -$652K | ﹤0.01% | 8415 |
|
|
2024
Q1 | $1.09M | Sell |
10,164
-13,752
| -58% | -$1.37M | ﹤0.01% | 6679 |
|
|
2023
Q4 | $2.39M | Buy |
+23,916
| New | +$2.34M | ﹤0.01% | 4995 |
|
|
2023
Q3 | – | Sell |
-3,143
| Closed | -$469K | – | 12427 |
|
|
2023
Q2 | $560K | Buy |
3,143
+524
| +20% | +$96.1K | ﹤0.01% | 8055 |
|
|
2023
Q1 | $432K | Sell |
2,619
-32,684
| -93% | -$5.62M | ﹤0.01% | 8912 |
|
|
2022
Q4 | $5.56M | Buy |
35,303
+29,357
| +494% | +$4.47M | ﹤0.01% | 3075 |
|
|
2022
Q3 | $895K | Buy |
+5,946
| New | +$989K | ﹤0.01% | 6924 |
|
|
2022
Q1 | – | Sell |
-17,652
| Closed | -$3.95M | – | 13437 |
|
|
2021
Q4 | $4.19M | Sell |
17,652
-14,233
| -45% | -$3.32M | ﹤0.01% | 4048 |
|
|
2021
Q3 | $7.44M | Buy |
31,885
+27,630
| +649% | +$5.79M | ﹤0.01% | 3307 |
|
|
2021
Q2 | $876K | Buy |
4,255
+737
| +21% | +$152K | ﹤0.01% | 8135 |
|
|
2021
Q1 | $723K | Buy |
+3,518
| New | +$743K | ﹤0.01% | 8575 |
|
|
2020
Q1 | – | Sell |
-4,591
| Closed | -$884K | – | 10521 |
|
|
2019
Q4 | $859K | Buy |
+4,591
| New | +$790K | ﹤0.01% | 5828 |
|
|
2019
Q3 | – | Sell |
-3,276
| Closed | -$652K | – | 10457 |
|
|
2019
Q2 | $825K | Buy |
+3,276
| New | +$759K | ﹤0.01% | 6131 |
|
|
2019
Q1 | – | Sell |
-5,504
| Closed | -$1.32M | – | 9293 |
|
|
2018
Q4 | $1.26M | Sell |
5,504
-48,940
| -90% | -$12.1M | ﹤0.01% | 4261 |
|
|
2018
Q3 | $15.4M | Buy |
54,444
+4,643
| +9% | +$1.36M | 0.01% | 1529 |
|
|
2018
Q2 | $14.6M | Buy |
49,801
+48,434
| +3,543% | +$13.2M | 0.01% | 1573 |
|
|
2018
Q1 | $345K | Sell |
1,367
-15,088
| -92% | -$3.55M | ﹤0.01% | 7381 |
|
|
2017
Q4 | $3.55M | Buy |
16,455
+6,000
| +57% | +$1.21M | ﹤0.01% | 2973 |
|
|
2017
Q3 | $1.94M | Sell |
10,455
-6,831
| -40% | -$1.19M | ﹤0.01% | 3967 |
|
|
2017
Q2 | $2.98M | Buy |
17,286
+6,794
| +65% | +$1.09M | ﹤0.01% | 3153 |
|
|
2017
Q1 | $1.6M | Sell |
10,492
-18,779
| -64% | -$2.74M | ﹤0.01% | 4134 |
|
|
2016
Q4 | $4.31M | Buy |
+29,271
| New | +$4.24M | ﹤0.01% | 2658 |
|
|
2016
Q1 | – | Sell |
-14,068
| Closed | -$1.35M | – | 9295 |
|
|
2015
Q4 | $1.59M | Sell |
14,068
-2,867
| -17% | -$317K | ﹤0.01% | 4516 |
|
|
2015
Q3 | $1.85M | Buy |
16,935
+2,439
| +17% | +$261K | ﹤0.01% | 4433 |
|
|
2015
Q2 | $1.39M | Buy |
14,496
+2,496
| +21% | +$233K | ﹤0.01% | 5493 |
|
|
2015
Q1 | $1.12M | Buy |
12,000
+8,173
| +214% | +$715K | ﹤0.01% | 5527 |
|
|
2014
Q4 | $313K | Sell |
3,827
-178
| -4% | -$13.6K | ﹤0.01% | 8055 |
|
|
2014
Q3 | $257K | Buy |
4,005
+135
| +3% | +$8.27K | ﹤0.01% | 8261 |
|
|
2014
Q2 | $235K | Buy |
+3,870
| New | +$228K | ﹤0.01% | 8798 |
|
|
2014
Q1 | – | Sell |
-3,264
| Closed | -$201K | – | 9121 |
|
|
2013
Q4 | $208K | Sell |
3,264
-5,098
| -61% | -$328K | ﹤0.01% | 8200 |
|
|
2013
Q3 | $568K | Buy |
8,362
+2,705
| +48% | +$193K | ﹤0.01% | 6219 |
|
|
2013
Q2 | $408K | Buy |
+5,657
| New | +$374K | ﹤0.01% | 6346 |
|
Other funds holding ICUI
JT
Jeff Yass's ICUI Position: Q2 2026 in Review
Jeff Yass reduced its ICU Medical (ICUI) stake by 35% in Q2 2026, selling an estimated $531K and leaving 7,481 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #7963.
Jeff Yass first reported a position in ICUI in Q2 2013 and has held it in 38 quarters since. The position peaked at $15.4M in Q3 2018. 286 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.
- Jeff Yass held 7,481 shares of ICU Medical worth $1.1M as of Q2 2026.
- Jeff Yass sold 4,075 ICU Medical shares in Q2 2026, an estimated $531K.
- ICU Medical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7963 holding.
- Jeff Yass first reported a position in ICU Medical in Q2 2013 and has held it in 38 quarters since.
- Jeff Yass's ICU Medical position peaked at $15.4M in Q3 2018.
- 286 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.